Condition · 1 treatment path
Neuroblastoma (Pediatric)
Neuroblastoma is a cancer of immature nerve cells, mainly affecting infants and young children. It usually starts in the adrenal gland or along the spine.
Send your imaging + plan. Board-reviewed opinion in 5–10 working days.
- Treatment paths
- 1Treatment paths
- Specialties
- 2Specialties
- Typical severity
- SevereTypical severity
About neuroblastoma (pediatric)
What to know
Signs include an abdominal lump, belly swelling, bone pain, tiredness, fever, or leg weakness from spinal pressure. Diagnosis involves urine tests, imaging such as MIBG scans, and a biopsy with genetic testing. Behaviour varies widely, from tumours that regress without treatment in babies to aggressive disease in older children.
Treatment depends on risk group. Low-risk disease may be observed or treated with surgery alone, while intermediate and high-risk disease uses chemotherapy, surgery, radiotherapy, high-dose chemotherapy with stem cell rescue and immunotherapy. Specialist paediatric oncology teams coordinate care. Treatment abroad is typically considered for high-risk disease, immunotherapy or second opinions.
Pre-flight workup
Tests to have already done
- Biopsy pathology with histology, MYCN amplification status and other genetic markers, which define risk group.
- Imaging staging: MRI or CT of the primary tumour and MIBG scan (or similar) to look for spread to bone and marrow.
- Urine catecholamine levels (VMA/HVA) and bone marrow biopsy results.
- Blood counts, kidney, liver and heart function, usually requested before chemotherapy.
- Details of age at diagnosis and any treatment given, with response assessments.
Second opinion
When to get a second look
- Risk classification was made without MYCN or other genetic testing.
- High-risk disease has been diagnosed and immunotherapy or stem-cell treatment options have not been discussed.
- Observation alone is proposed for a young infant, and you want the reasoning confirmed.
- The disease has relapsed or not responded to initial treatment.
Talking to your doctor
Questions to ask
- What stage and risk group is my child's neuroblastoma?
- Can the tumour be removed fully, and what are the surgical risks?
- What chemotherapy, radiotherapy or immunotherapy do you recommend?
- Is stem-cell transplant part of the plan?
- What are the long-term effects, including hearing and growth?
- How often will scans and tests be repeated afterwards?
Outlook
Realistic prognosis
Outlook varies widely by age, stage and tumour biology. Infants with localised disease often have excellent outcomes, and some tumours regress on their own. Low- and intermediate-risk disease is usually curable, while high-risk disease, often presenting in older children with spread, is much harder to treat despite intensive multimodal therapy. MYCN amplification and age over about 18 months carry a poorer outlook. Long-term follow-up for late effects is essential.
01 · Specialties
Specialties that treat Neuroblastoma
Diagnostic workup
Before you pick a hospital, get the workup right
Picking the right treatment is downstream of a complete diagnosis. Skip steps here and the destination surgeon usually re-orders them anyway — at higher cost and another week on the ground.
- Confirm the diagnosis on imaging or labs
For neuroblastoma (pediatric), plan on the workup your home doctor would order anyway — typically a recent specialist consult plus the imaging / labs the destination team will need to quote accurately. Anything older than 90 days usually gets re-done.
- See a oncology specialist locally first
An in-person clinical exam at home — even a single consult — costs little and dramatically improves the destination plan. Bring back: written impression, recommended procedure, surgical-risk class, and any contra-indications.
- Send us the file for a free second opinion
Two surgeons in our medical panel review the workup independently. They tell you whether they'd operate, watch, or refer — even if that means recommending against travel.
- Pick a path with timeline + cost in writing
Once a treatment is the right call, we line up 2–3 hospital options with itemized quotes, surgeon profiles, and a travel timeline. You hold the file — switch hospitals or step away at any point.
03 · Treatment paths
Treatment options
Where to be treated
Neuroblastoma (Pediatric) treatment by destination
04 · FAQ
Common questions about neuroblastoma (pediatric)
Can neuroblastoma go away by itself?
In some infants, particularly very young ones with certain types, the tumour can regress, so observation may be appropriate.
Is surgery enough?
For low-risk localised disease, often yes. Higher-risk disease needs additional treatment such as chemotherapy and immunotherapy.
Why do they test the tumour genes?
Genetic features such as MYCN amplification predict behaviour and guide how intensive treatment should be.
Can my child travel during treatment?
Only with oncology team agreement, because blood counts and infection risk change through treatment.
Clinical context
Working up neuroblastoma (pediatric) properly
A condition like neuroblastoma (pediatric) is rarely well-served by jumping straight to treatment shopping. The sequence below is what a oncology specialist would expect to see completed — and the absence of any step is the right cue to delay travel decisions.
Diagnostic workup, in sequence
- First-line clinical assessment
History, physical exam, and risk-factor review by a senior generalist or oncology specialist. Symptoms list, family history, prior workup notes, and current medication list should travel with the patient.
- Standard imaging + labs
Baseline blood work, condition-specific imaging (ultrasound / X-ray / MRI / CT — depending on indication), and ECG / pulmonary function as relevant. Bring digital copies of any prior imaging — saves repeat scans and the cost that goes with them.
- Specialist diagnostic workup
Procedure-specific tests — biopsy, cardiac catheterisation, endoscopy, or genetic / molecular profiling depending on the suspected diagnosis. Done at the centre that will treat, ideally, so results integrate cleanly into the treatment plan.
- Multidisciplinary review (where indicated)
Cancer, complex cardiac, transplant, and rare-disease cases should be reviewed by a multidisciplinary panel — surgical, medical, imaging, and pathology — before any treatment commits. Single-discipline plans for complex disease are a quality red flag.
When to escalate urgently
- Acute worsening of established symptoms — sudden chest pain, shortness of breath at rest, neurological deficit, severe bleeding, persistent high fever.
- Loss of consciousness, severe persistent vomiting, or any focal neurological event.
- Symptoms in the early hours of onset that fit a time-sensitive treatment window (stroke, MI, sepsis) — every hour costs outcome.
- If you are travelling internationally for treatment and develop these symptoms in transit, divert to the nearest emergency department; do not wait to reach the planned destination.
Before you book international travel
- Confirm your specific diagnosis is fully worked up before you commit to a treatment plan abroad. Travelling for the workup is fine; travelling for treatment without the workup done is not.
- Get your case reviewed remotely by the destination centre's team before you book flights — credible international patient programs review imaging + reports before they confirm the surgical plan.
- Bring a digital + physical copy of your full medical record: imaging on USB drive in DICOM format, labs in PDF, current medication list with dosages, allergies, and any prior surgical reports.
- Plan for longer recovery + post-discharge therapy continuation before you fly — the surgery itself is rarely the bottleneck.
- Confirm that follow-up imaging and any necessary in-person reviews can be done at home — a treatment plan that requires repeat international trips is more burdensome (and more expensive) than the headline procedure.
Methodology and editorial standards
This neuroblastoma (pediatric) overview is written by the editorial team from published Oncology sources and lists 1 treatment options offered by hospitals on our network. The page shows its last-updated date. Clinical descriptions are editorial — your treating clinician confirms what's right for your specific case.
- Hospital data. Hospital details are compiled from public sources and hospital websites. Accreditation (JCI, NABH and others) is shown where we hold a record of it. Always ask the hospital for its current certificate.
- Doctor credentials. Qualifications, specialty and bio come from the doctor's hospital profile. Licence is checked against the national medical-council register only where the profile shows a "Licence verified" badge with a date.
- Prices. Price ranges are indicative, compiled from hospital price lists and packages and shown with the date last updated. The hospital's written quote is what you pay against.
- Clinical text. Written by the Medcasts editorial team from published clinical sources. Unless a named reviewer is shown on the page, it has not been reviewed by a doctor.
- Independence. Hospitals cannot pay to change their position on our pages.
Neuroblastoma (Pediatric)
Continue evaluating neuroblastoma (pediatric) care
Condition overview is one entry. These hubs route the same care decision via specialty, surgeon, treatment, and destination — including the doctors actively treating neuroblastoma (pediatric).
- Surgeons Doctors treating Neuroblastoma (Pediatric) Volume-ranked specialists across all relevant specialties.
- Specialty Oncology hub Programs, surgeons, hospitals across oncology.
- Specialty Pediatric Surgery Alternative specialty involved in care for this condition.
- Procedure Neuroblastoma Resection First-line treatment with success rates, recovery, hospital pricing.
- Browse All 79 conditions Map condition → specialty → first-line treatment.
- Browse 9 destination countries Cost-of-care profiles, hospital programs, visa playbooks.
- Compare Hospital comparison Side-by-side accreditations, ratings, beds, and pricing.
- Compare Doctor comparison Surgeons compared on volume, fees, languages, video-consult availability.
- Tool Match-me triage Three questions, get a specialty + destination + 3-hospital shortlist.
- Tool Cost calculator Hospital-reported pricing across procedures × destinations.
- Action Free second opinion Independent panel review of your case in 48 hours — no charge.
Next step · Neuroblastoma (Pediatric)
Free second opinion on your Neuroblastoma case.
Share imaging and the current plan. Multidisciplinary board returns a written opinion within 5–10 working days — no obligation to travel.